Skip to main content

Advertisement

Log in

Clinical analysis of 90 cases of malignant lacrimal sac tumor

  • Oncology
  • Published:
Graefe's Archive for Clinical and Experimental Ophthalmology Aims and scope Submit manuscript

Abstract

Purpose

To investigate the pathology, clinical manifestations, and potential risk factors associated with the prognosis of malignant lacrimal sac tumors. In addition, the treatment outcomes and complications were also evaluated.

Methods

Ninety cases of malignant lacrimal sac tumors were retrospectively analyzed at our hospital. Pathological classifications, clinical manifestations, risk factors, and follow-up time were documented. The outcomes and complications were evaluated and compared among the various treatment modalities.

Results

The median follow-up time was 50 months (range, 3–258 months). The 5-year overall survival (OS) and progression-free survival (PFS) for all cases were 85.7 and 77.9%, respectively. The 5-year OS and PFS for 69 cases of squamous cell carcinoma were 87.6 and 76.3%, and which were 80.4 and 72.4% for 21 cases of non-squamous cell carcinoma, respectively. There was no difference of 5-year OS and PFS between squamous cell carcinoma and non-squamous cell carcinoma (p = 0.350 and p = 0.946). Positive lymph node status was associated with worse OS (p < 0.001) and PFS (p = 0.020). For the 23.3% of cases (21/90) treated with the definitive radiotherapy, the outcomes were equivalent to that of surgery combined with radiotherapy, with the incidence of treatment-related visual acuity complication not being significant. The addition of chemotherapy to the treatment course had a marginal and non-significant improvement in OS and distant metastasis-free survival.

Conclusions

Lymph node status was found to be a key factor for prognosis. Advanced tumors could benefit from multimodality treatment, with radiotherapy playing an important role. However, the role of chemotherapy requires further investigation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Wladis EJ, Frempong T, Gausas R (2007) Nasolacrimal metastasis from heptocellular carcinoma masquerading as dacryocystitis. Ophthal Plast Reconstr Surg 23(4):333–335

    Article  PubMed  Google Scholar 

  2. Vozmediano-Serrano MT, Toledano-Fernandez N, Fdez-Acenero MJ, Gil-Diez JL, Garcia-Saenz S (2006) Lacrimal sac metastases from renal cell carcinoma. Orbit (Amsterdam, Netherlands) 25(3):249–251

    CAS  Google Scholar 

  3. Krishna Y, Coupland SE (2017) Lacrimal sac tumours—a review. Asia Pac J Ophthalmol 6(2):173–178

    Article  Google Scholar 

  4. Hodgson N, Whipple K, Lin JH, Brumund KT, Kikkawa DO, Korn BS (2013) Bilateral squamous cell carcinoma of the lacrimal sac. Ophthal Plast Reconstr Surg 29(6):e149–e151

    Article  PubMed  PubMed Central  Google Scholar 

  5. Lee LN, Scott AR, Chan AW, Frankenthaler RA (2010) Management of transitional cell carcinoma of the lacrimal sac: a multidisciplinary approach to orbit sparing treatment. Laryngoscope 120(Suppl 4):S161

    Article  PubMed  Google Scholar 

  6. Goto T, Bandoh N, Nagato T, Takahara M, Harabuchi Y, Tokusashi Y et al (2010) Primary small cell carcinoma of lacrimal sac: case report and literature review. J Laryngol Otol 124(11):1223–1226

    Article  PubMed  CAS  Google Scholar 

  7. Bi YW, Chen RJ, Li XP (2007) Clinical and pathological analysis of primary lacrimal sac tumours. Zhonghua Yan Ke Za Zhi 43(6):499–504

    PubMed  Google Scholar 

  8. Sjo LD, Ralfkiaer E, Juhl BR, Prause JU, Kivela T, Auw-Haedrich C et al (2006) Primary lymphoma of the lacrimal sac: an EORTC ophthalmic oncology task force. Br J Ophthalmol 90(8):1004–1009

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. Koturovic Z, Knezevic M, Rasic DM (2017) Clinical significance of routine lacrimal sac biopsy during dacryocystorhinostomy: a comprehensive review of literature. Bosn J Basic Med Sci 17(1):1–8

    PubMed  PubMed Central  Google Scholar 

  10. Merkonidis C, Brewis C, Yung M, Nussbaumer M (2005) Is routine biopsy of the lacrimal sac wall indicated at dacryocystorhinostomy? A prospective study and literature review. Br J Ophthalmol 89(12):1589–1591

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  11. Anderson NG, Wojno TH, Grossniklaus HE (2003) Clinicopathologic findings from lacrimal sac biopsy specimens obtained during. Ophthal Plast Reconstr Surg 19(3):173–176

    Article  PubMed  Google Scholar 

  12. Ni C, D’ Amico DJ, Fan CQ, Kuo PK (1982) Tumours of the lacrimal sac: a clinicopathological analysis of 82 cases. Int Ophthalmol Clin 22(1):121–140

    Article  PubMed  CAS  Google Scholar 

  13. Alabiad CR, Weed DT, Walker TJ, Vivero R, Hobeika GA, Hatoum GF et al (2014) En bloc resection of lacrimal sac tumors and simultaneous orbital reconstruction. Ophthal Plast Reconstr Surg 30(6):459–467

    Article  PubMed  Google Scholar 

  14. Montalban A, Lietin B, Louvrier C, Russier M, Kemeny JL, Mom T et al (2010) Malignant lacrimal sac tumours. Eur Ann Otorhinolaryngol Head Neck Dis 127(5):165–172

    Article  PubMed  CAS  Google Scholar 

  15. Ramos A, Pozo CD, Chinchurreta A, Garcia F, Lorenzo M, Gismero S (2016) Adenoid cystic carcinoma of the lacrimal sac: case report. Arq Bras Oftalmol 79(5):333–335

    Article  PubMed  Google Scholar 

  16. Parmar DN, Rose GE (2003) Management of lacrimal sac tumours. Eye 17(5):599–606

    Article  PubMed  CAS  Google Scholar 

  17. El-Sawy T, Frank SJ, Hanna E, Sniegowski M, Lai SY, Nasser QJ et al (2013) Multidisciplinary management of lacrimal sac/nasolacrimal duct carcinomas. Ophthal Plast Reconstr Surg 29(6):454–457

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shengzi Wang.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

The study was approved by the Medical Ethical Committee of the EENT Hospital. Research was performed in accordance with the Declaration of Helsinki.

Patient consent

Informed consent was obtained from all individual participants included in the study.

Additional information

Xinmao Song and Jie Wang contribute equally to this work, and they are co-first authors.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Song, X., Wang, J., Wang, S. et al. Clinical analysis of 90 cases of malignant lacrimal sac tumor. Graefes Arch Clin Exp Ophthalmol 256, 1333–1338 (2018). https://doi.org/10.1007/s00417-018-3962-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00417-018-3962-4

Keywords

Navigation